![MGC Pharmaceuticals Announces Its First Tranche Of Funding Has Been Received Under New Financing Facility - Business of Cannabis MGC Pharmaceuticals Announces Its First Tranche Of Funding Has Been Received Under New Financing Facility - Business of Cannabis](https://businessofcannabis.com/wp-content/uploads/2022/01/BusinessCann-Press-Release-Template-Synbiotic-16-e1653295195343.png)
MGC Pharmaceuticals Announces Its First Tranche Of Funding Has Been Received Under New Financing Facility - Business of Cannabis
![Something Fishy: What Pharma News Releases Don't Tell You - MedShadow Foundation | Independent Health & Wellness Journalism Something Fishy: What Pharma News Releases Don't Tell You - MedShadow Foundation | Independent Health & Wellness Journalism](https://medshadow.org/wp-content/uploads/2019/03/pressrelease.jpg)
Something Fishy: What Pharma News Releases Don't Tell You - MedShadow Foundation | Independent Health & Wellness Journalism
![MaaT Pharma announces successful Initial Public Offering on the regulated market of Euronext Paris - MaaT Pharma MaaT Pharma announces successful Initial Public Offering on the regulated market of Euronext Paris - MaaT Pharma](https://www.maatpharma.com/wp-content/uploads/2021/11/1-1.jpg)
MaaT Pharma announces successful Initial Public Offering on the regulated market of Euronext Paris - MaaT Pharma
![JRS PHARMA is pleased to announce cDMF filings with the NMPA for many of their excipient products for use in China. - Pharma Excipients JRS PHARMA is pleased to announce cDMF filings with the NMPA for many of their excipient products for use in China. - Pharma Excipients](https://www.pharmaexcipients.com/wp-content/uploads/2019/08/Press-release-JRS-.gif)
JRS PHARMA is pleased to announce cDMF filings with the NMPA for many of their excipient products for use in China. - Pharma Excipients
![Eir Ventures completes seed-financing of Sortina Pharma with GU Ventures to develop breakthrough cancer treatments | EIR Ventures Eir Ventures completes seed-financing of Sortina Pharma with GU Ventures to develop breakthrough cancer treatments | EIR Ventures](https://eirventures.eu/wp-content/uploads/2021/01/sortina-pharma-press-release.png)
Eir Ventures completes seed-financing of Sortina Pharma with GU Ventures to develop breakthrough cancer treatments | EIR Ventures
![MaaT Pharma announces successful Initial Public Offering on the regulated market of Euronext Paris - MaaT Pharma MaaT Pharma announces successful Initial Public Offering on the regulated market of Euronext Paris - MaaT Pharma](https://www.maatpharma.com/wp-content/uploads/2021/11/2-2.jpg)